ArticleSurgical case reports2026
Emergency Cholecystectomy for Gangrenous Acute Cholecystitis with Profound Thrombocytopenia: Immune Thrombocytopenia Diagnosed Postoperatively.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe optimal source-control strategy for gangrenous acute cholecystitis in patients with profound thrombocytopenia remains unclear. Moreover, infection-associated and immune thrombocytopenia may be difficult to distinguish during the acute phase. CASE PRESENTATION: A 76-year-old man with hypertension, diabetes mellitus, and a history of open distal gastrectomy for gastric cancer presented with gangrenous acute cholecystitis and profound thrombocytopenia (2000/μL). Infection-associated consumptive thrombocytopenia was initially considered, and emergency open cholecystectomy was performed following platelet transfusion. Thrombocytopenia persisted despite source control, and the response to platelet transfusion was suboptimal. The overall clinical course, exclusion of alternative causes, and preserved trilineage hematopoiesis on bone marrow examination supported a clinical diagnosis of immune thrombocytopenia. Treatment with dexamethasone,
conclusionsThis case highlights the necessity of balancing urgent source control against substantial bleeding risk in gangrenous acute cholecystitis with profound thrombocytopenia. Persistent thrombocytopenia following surgical source control, particularly with a suboptimal response to platelet transfusion, should prompt reassessment of the underlying etiology, including immune thrombocytopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.